Faculty profile

Amy Liu

Back to faculty

Assistant ProfessorBiostatistics DivisionUniversity of Toronto

Signals and details

Latest papers

Patient-reported Quality of Life in PROFIT, a Phase 3 Randomized Clinical Trial Evaluating Moderately Hypofractionated Radiotherapy for Intermediate-risk Prostate Cancer
European Urology Oncology · 2026
Gastro-Esophageal Cancer: Can Radiomic Parameters from Baseline 18F-FDG-PET/CT Predict the Development of Distant Metastatic Disease?
Diagnostics (Basel, Switzerland) · 2024
High grade adverse event reporting and enrolment in gynecologic oncology clinical trials.
Gynecologic oncology · 2024

All 10 publications

10 publications.

Patient-reported Quality of Life in PROFIT, a Phase 3 Randomized Clinical Trial Evaluating Moderately Hypofractionated Radiotherapy for Intermediate-risk Prostate Cancer

Sanmamed N, Dayes I, Catton C, Liu A, Supiot S, Lukka H, Bauman G, Liu Z, Bahary J-P, Ahmed S

European Urology Oncology20265 citations

DOI: 10.1016/j.euo.2025.03.017

Gastro-Esophageal Cancer: Can Radiomic Parameters from Baseline 18F-FDG-PET/CT Predict the Development of Distant Metastatic Disease?

Hinzpeter R, Mirshahvalad SA, Kulanthaivelu R, Kohan A, Ortega C, Metser U, Liu A, Farag A, Elimova E, Wong RKS, Yeung J, Jang RW, Veit-Haibach P

Diagnostics (Basel, Switzerland)2024

DOI: 10.3390/diagnostics14111205 PMID: 38893731

High grade adverse event reporting and enrolment in gynecologic oncology clinical trials.

Madariaga A, Cole H, Pittman T, Grant RC, Dhani NC, Liu A, Bowering V, Sellman S, Oza AM, Lheureux S

Gynecologic oncology2024

DOI: 10.1016/j.ygyno.2024.02.003 PMID: 38342004

Late Cardiac Toxic Effects Associated With Treatment Protocols for Hodgkin Lymphoma in Children.

Lo AC, Liu A, Liu Q, Yasui Y, Castellino SM, Kelly KM, Hererra AF, Friedberg JW, Friedman DL, Schwartz CL, Pei Q, Kessel S, Bergeron-Gravel S, Dama H, Roberts K, Constine LS, Hodgson DC

JAMA network open2024

DOI: 10.1001/jamanetworkopen.2023.51062 PMID: 38241048

Evaluation of dosimetric predictors of toxicity after IMRT with concurrent chemotherapy for anal cancer.

Lukovic J, Hosni A, Liu A, Chen J, Tadic T, Patel T, Li K, Han K, Lindsay P, Craig T, Brierley J, Barry A, Wong R, Ringash J, Dawson LA, Kim JJ

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2023

DOI: 10.1016/j.radonc.2022.11.018 PMID: 36455685

The Feasibility of Quality Assurance in the TOPGEAR International Phase 3 Clinical Trial of Neoadjuvant Chemoradiation Therapy for Gastric Cancer (an Intergroup Trial of the AGITG/TROG/NHMRC CTC/EORTC/CCTG).

Lukovic J, Moore AJ, Lee MT, Willis D, Ahmed S, Akra M, Hortobagyi E, Kron T, Lim Joon D, Liu A, Ryan J, Thomas M, Wall K, Ward I, Wiltshire KL, O'Callaghan CJ, Wong RKS, Ringash JG, Haustermans K, Leong T

International journal of radiation oncology, biology, physics2023

DOI: 10.1016/j.ijrobp.2023.06.011 PMID: 37393022

Quantitative 68Ga-DOTATATE PET/CT Parameters for the Prediction of Therapy Response in Patients with Progressive Metastatic Neuroendocrine Tumors Treated with 177Lu-DOTATATE

Ortega C, Wong RKS, Schaefferkoetter J, Veit-Haibach P, Myrehaug S, Juergens R, Laidley D, Anconina R, Liu A, Metser U

Journal of Nuclear Medicine202179 citationsOpen Access

DOI: 10.2967/jnumed.120.256727 PMID: W3128650343

Oncocytic Papillary Thyroid Carcinoma and Oncocytic Poorly Differentiated Thyroid Carcinoma: Clinical Features, Uptake, and Response to Radioactive Iodine Therapy, and Outcome.

Lukovic J, Petrovic I, Liu Z, Armstrong SM, Brierley JD, Tsang R, Pasternak JD, Gomez-Hernandez K, Liu A, Asa SL, Mete O

Frontiers in endocrinology2021

DOI: 10.3389/fendo.2021.795184 PMID: 34975765

Detection of clinically significant prostate cancer with 18F-DCFPyL PET/multiparametric MR.

Metser U, Ortega C, Perlis N, Lechtman E, Berlin A, Anconina R, Eshet Y, Chan R, Veit-Haibach P, van der Kwast TH, Liu A, Ghai S

European journal of nuclear medicine and molecular imaging2021

DOI: 10.1007/s00259-021-05355-7 PMID: 33846845

Long-term survival of head and neck squamous cell carcinoma after bone marrow transplant.

Douglas CM, Jethwa AR, Hasan W, Liu A, Gilbert R, Goldstein D, De Almedia J, Lipton J, Irish JC

Head & neck2020

DOI: 10.1002/hed.26402 PMID: 32820585

Profile data last refreshed on July 30, 2025 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

Amy Liu

Latest papers

Patient-reported Quality of Life in PROFIT, a Phase 3 Randomized Clinical Trial Evaluating Moderately Hypofractionated Radiotherapy for Intermediate-risk Prostate Cancer

Gastro-Esophageal Cancer: Can Radiomic Parameters from Baseline 18F-FDG-PET/CT Predict the Development of Distant Metastatic Disease?

High grade adverse event reporting and enrolment in gynecologic oncology clinical trials.

Late Cardiac Toxic Effects Associated With Treatment Protocols for Hodgkin Lymphoma in Children.

Evaluation of dosimetric predictors of toxicity after IMRT with concurrent chemotherapy for anal cancer.

The Feasibility of Quality Assurance in the TOPGEAR International Phase 3 Clinical Trial of Neoadjuvant Chemoradiation Therapy for Gastric Cancer (an Intergroup Trial of the AGITG/TROG/NHMRC CTC/EORTC/CCTG).

Quantitative 68Ga-DOTATATE PET/CT Parameters for the Prediction of Therapy Response in Patients with Progressive Metastatic Neuroendocrine Tumors Treated with 177Lu-DOTATATE

Oncocytic Papillary Thyroid Carcinoma and Oncocytic Poorly Differentiated Thyroid Carcinoma: Clinical Features, Uptake, and Response to Radioactive Iodine Therapy, and Outcome.

Detection of clinically significant prostate cancer with 18F-DCFPyL PET/multiparametric MR.

Long-term survival of head and neck squamous cell carcinoma after bone marrow transplant.

Frequent collaborators

Jelena Lukovic

Patrick Veit-Haibach

Ian Stuart Dayes

Glenn Bauman

Nathan Perlis

Alejandro Berlin

Rosalyn Juergens

Elena Elimova

Jonathan Yeung

Stephanie Lheureux

Kathy Han

Theos Tsakiridis